Brucellosis is a bacterial zoonotic disease which has been associated with laboratory-
acquired infections. No recent reviews have addressed the characteristics of laboratory …

Brucellae are class 3 organisms and potential agents of bioterrorism. Because of effective
public health measures, brucellosis has become a rare disease in industrialized countries …

Brucella abortus strain RB51 vaccine, is an attenuated live bacterial vaccine that was
licensed conditionally by the Center for Veterinary Biologics, Veterinary Services, Animal …

The successful control of animal brucellosis and associated reduction in human exposure
has limited the development of human brucellosis vaccines. However, the potential use of …

From May to September 1988, eight employees of a microbiology laboratory developed
acute brucellosis (attack rate, 31%). Seven of the eight affected employees had clinical …

This chapter examines the extent of documented laboratory‐associated infections (LAIs)
classified as viral, parasitic, bacterial, fungal, including rickettsial infection by reviewing …

Brucellosis is an anthropozoonosis which is always traceable to animals. Human disease is
the accidental expression of the much more widespread disease in animals. It was first …

Brucellosis is one of the most prevalent zoonotic infections worldwide. 1 The half million
reported new cases per year likely represents a gross underestimate related to challenges …

The clinical manifestations of human brucellosis are protean and the diversity of nonspecific
complaints poses a challenge to clinicians, especially in countries where the disease is now …

Vaccination of humans and animals with live attenuated organisms has proven to be an
effective means of combatting some important infectious diseases. In fact, the 20th century …